Skip to main content
| News

Basel is very open to newcomers

03.06.2021

In an interview that was published in “network mag”, Novartis CEO Vas Narasimhan talks about diversity at Novartis and his positive experience of living in Basel.

Novartis CEO Vas Narasimhan
Vas Narasimhan (image: Novartis)

In 2018, Vas Narasimhan became CEO of pharmaceutical company Novartis. The American, his wife and two sons have lived in Basel for more than ten years. With “network mag”, Vas Narasimhan shared his view on diversity and inclusion and on living in Basel.

Asked about his experience of living in Switzerland, Narasimhan answers: “Nestled in the heart of Europe, I’ve found that Basel is very internationally minded and open to newcomers. This may be because it is a border town and because historically immigrants have found their way to Basel, including some of the founders of the pharmaceutical and chemical companies that have become global leaders. When you think that Novartis and our predecessor companies have been shipping goods from here for over 250 years, you realize how closely this place has been linked to the world over the past centuries. My experience here has only been positive.”

Narasimhan also told the magazine that Basel became his and his family’s home by now. He also revealed what he likes best about living in Switzerland: “Switzerland is a great place to live, and I am very happy here. The landscape is breathtaking, and there is good social and healthcare infrastructure. The overall quality of life here is very high. There’s a lot to love!”

Novartis is one of the biggest pharmaceutical companies in the world. It’s global headquarters are located in Basel. More than 104’000 employees work for Novartis around the globe. In 2020, the company had a turnover of 48.7 billion dollars and reported a net profit of 8.1 billion dollars.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation, Invest, Sustainability

KUORI developing biodegradable plastics

The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Cell and gene therapies gain momentum in Basel

Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...

Read More
BLKB expanding support for startups
Basel Area Business & Innovation, Innovation, Invest

BLKB expanding support for startups

BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...

Read More
Combatting the rise of antimicrobial resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Combatting the rise of antimicrobial resistance

Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

AMR Action Fund invests in new antibiotics developed by BioVersys

The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Investors give Resistell 8.5 million Swiss francs

Resistell AG has secured 8.5 million Swiss francs in the first part of its series B funding round. The biotechnology...

Read More
1 2 3 60

Do you have a question? We'd like to hear from you.